Orphazyme: Discouraging Results in sIBM
Research Note
2021-03-29
08:53
Redeye provides the first comment to the top-line results presented with arimoclomol in sIBM. We will come back with a more thorough update during the day.
AH
Anders Hedlund
Disclosures and disclaimers